Related Experiment Videos
Rho-modifying C3-like ADP-ribosyltransferases.
K Aktories1, C Wilde, M Vogelsgesang
1Institute of Experimental and Clinical Pharmacology and Toxicology, Albert-Ludwigs University Freiburg, Otto-Krayer-Haus, Albertstr. 25, Freiburg, Germany. Klaus.Aktories@pharmakol.uni-freiburg.de.
Reviews of Physiology, Biochemistry and Pharmacology
|September 17, 2004
Summary
C3-like exoenzymes are bacterial enzymes that modify Rho GTPases. New research reveals the functional consequences of this modification are more complex than previously understood.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- C3-like exoenzymes are a family of bacterial ADP-ribosyltransferases.
- These enzymes selectively modify RhoA, B, and C GTPases at asparagine-41.
- Available crystal structures offer insights into exoenzyme structure-function relationships.
Purpose of the Study:
- To review the fundamental properties of C3 exoenzymes.
- To present and discuss recent findings on the functional consequences of C3-induced ADP-ribosylation.
- To explore the complexity of Rho GTPase inhibition by C3 exoenzymes.
Main Methods:
- Review of existing literature and structural data.
- Analysis of recent experimental findings on C3 exoenzyme activity.
- Synthesis of information regarding Rho GTPase function and inhibition.
Main Results:
- C3 exoenzymes inhibit Rho GTPase functions via ADP-ribosylation.
- The functional outcomes of C3-induced ADP-ribosylation are more intricate than initially presumed.
- Structural information aids in understanding enzyme-substrate interactions.
Conclusions:
- C3 exoenzymes are valuable pharmacological tools for studying Rho GTPase biology.
- Emerging evidence highlights a more nuanced understanding of C3 exoenzyme mechanisms and effects.
- Further research is warranted to fully elucidate the complex functional consequences.